Capstone Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $848K | Buy |
18,324
+577
| +3% | +$26.7K | 0.05% | 72 |
|
2025
Q1 | $1.08M | Sell |
17,747
-102
| -0.6% | -$6.22K | 0.07% | 59 |
|
2024
Q4 | $1.01M | Sell |
17,849
-4,585
| -20% | -$259K | 0.06% | 63 |
|
2024
Q3 | $1.16M | Sell |
22,434
-23
| -0.1% | -$1.19K | 0.07% | 54 |
|
2024
Q2 | $933K | Buy |
22,457
+319
| +1% | +$13.2K | 0.06% | 59 |
|
2024
Q1 | $1.2M | Buy |
22,138
+7,930
| +56% | +$430K | 0.08% | 50 |
|
2023
Q4 | $729K | Sell |
14,208
-56
| -0.4% | -$2.87K | 0.05% | 64 |
|
2023
Q3 | $828K | Sell |
14,264
-401
| -3% | -$23.3K | 0.07% | 56 |
|
2023
Q2 | $938K | Buy |
14,665
+964
| +7% | +$61.6K | 0.07% | 54 |
|
2023
Q1 | $950K | Buy |
13,701
+228
| +2% | +$15.8K | 0.08% | 51 |
|
2022
Q4 | $969K | Sell |
13,473
-1,112
| -8% | -$80K | 0.08% | 47 |
|
2022
Q3 | $1.04M | Sell |
14,585
-128
| -0.9% | -$9.1K | 0.1% | 46 |
|
2022
Q2 | $1.13M | Sell |
14,713
-582
| -4% | -$44.8K | 0.1% | 46 |
|
2022
Q1 | $1.12M | Buy |
15,295
+7,455
| +95% | +$544K | 0.08% | 48 |
|
2021
Q4 | $489K | Buy |
7,840
+659
| +9% | +$41.1K | 0.04% | 79 |
|
2021
Q3 | $425K | Buy |
7,181
+85
| +1% | +$5.03K | 0.03% | 77 |
|
2021
Q2 | $474K | Buy |
7,096
+47
| +0.7% | +$3.14K | 0.04% | 73 |
|
2021
Q1 | $445K | Buy |
7,049
+1,851
| +36% | +$117K | 0.04% | 69 |
|
2020
Q4 | $322K | Buy |
5,198
+1,348
| +35% | +$83.5K | 0.03% | 77 |
|
2020
Q3 | $232K | Hold |
3,850
| – | – | 0.02% | 89 |
|
2020
Q2 | $226K | Hold |
3,850
| – | – | 0.03% | 81 |
|
2020
Q1 | $215K | Hold |
3,850
| – | – | 0.03% | 73 |
|
2019
Q4 | $247K | Buy |
+3,850
| New | +$247K | 0.03% | 70 |
|